2025 Medicare Coverage Gap

Trying to figure out Medicare Advantage plans in 2025? Once your spending hits $5,030, you’ll find yourself in the ‘donut hole’. Here, you’re responsible for up to 25% of your medication costs. Our guide demystifies the coverage gap and arms you with practical tips to manage and reduce your drug spending during this phase.


Key Takeaways

  • The 2025 Medicare Part D coverage gap, or ‘donut hole’, begins once an individual and their plan spend $5,030 on covered drugs, with beneficiaries responsible for 25% of their medication costs in this phase.


  • In the Inflation Reduction Act of 2025, changes to Medicare Part D include a prescription drug spending cap to lower out-of-pocket expenses and provisions for Medicare to negotiate drug prices, affecting future drug costs and premiums.


  • Starting in 2025, significant changes to Medicare Part D will apply, including the elimination of the coverage gap, a $2,000 cap on out-of-pocket costs, and the removal of the 5% coinsurance after reaching the catastrophic phase.

Compare plans & rates for 2025
Enter Zip Code


The 2025 Medicare Coverage Gap Explained


2025 Medicare Coverage Gap 2025 Medicare Coverage Gap The 2025 Medicare Coverage Gap Explained


The Medicare coverage gap, colloquially known as the ‘donut hole’, is a phase within the Medicare Part D prescription drug benefit. This phase starts once a certain threshold is reached within the beneficiary’s plan term.

For 2025, this threshold is set at $5,030 spent on covered drugs, a combined total that includes spending by both the beneficiary and their Medicare Part D drug plan.

During this phase, beneficiaries shoulder a significant part of their drug costs. Yet, under the 2025 plan, brand-name and generic prescription drugs covered by your plan will not cost you more than 25% of their price. While this might seem daunting, understanding the specifics can help you manage your costs better.


The Start of the Coverage Gap

As highlighted before, the coverage gap phase commences once you and your drug plan incur a total expenditure of $5,030 on covered drugs in 2025. Known as the initial coverage limit, this total comprises your deductible, your copayments, and your insurance company’s contribution towards covered drugs.

This phase is often referred to as the ‘donut hole’ because, like a donut, there’s a substance on either side with a gap in between. In the context of Medicare, there’s coverage on either side (the initial coverage phase and the catastrophic coverage phase), with a gap in the middle where you pay more out-of-pocket for your prescription drugs.


Out-of-Pocket Costs During the Gap

Within the coverage gap phase, the following will apply:

  • 25% of the cost for your plan’s covered brand-name prescription drugs will be your responsibility


  • This can result in increased out-of-pocket expenses for you


  • Manufacturers provide a 70% discount on brand-name drugs


  • Plans will pay the remaining 5% of brand drug costs


Regarding generic drugs, Medicare shoulders 75% of the cost during the coverage gap, leaving you to cover the remaining 25%. However, only the amount you pay for generic drugs counts towards the out-of-pocket threshold to get out of the coverage gap. Understanding these nuances can help you manage your out-of-pocket costs more effectively.


Exiting the Coverage Gap

To exit the coverage gap, one must reach a specific threshold in True Out-of-Pocket Costs (TrOOP). In 2025, this threshold is $8,000. Items that count towards this out-of-pocket cost include:

  • Yearly deductible


  • Coinsurance


  • Copayments


  • Discounts received on brand-name drugs in the gap


Not all expenses contribute to this threshold, however. The drug plan premium, pharmacy dispensing fee, and payments for non-covered drugs do not count toward exiting the coverage gap. So, it’s important to keep track of your expenses and understand what counts towards your TrOOP.

Navigating the Four Phases of Medicare Part D in 2025


2025 Medicare Coverage Gap Navigating the Four Phases of Medicare Part D in 2025


Medicare Part D provides outpatient prescription drug coverage to individuals with Medicare through private plans that are contracted with the federal government. It is a voluntary benefit that helps beneficiaries access necessary medications. The Part D benefit consists of four phases:

  1. Deductible phase
  2. Initial coverage phase
  3. Coverage gap phase
  4. Catastrophic coverage phase

Each phase has a different cost-sharing structure, which we will explain in detail.

Beneficiaries’ monthly premiums for Part D are designed to cover approximately 25.5% of the cost of standard drug coverage. The remainder is subsidized by Medicare, which is based on plans’ bids for expected benefit payments. Comprehending these phases and the cost-sharing dynamics is vital for individuals managing their Part D drug coverage.


Deductible Phase

The deductible phase is the first part of Medicare Part D. During this phase, you are responsible for paying out-of-pocket for your prescription drugs up to a certain limit before your coverage kicks in.

In 2025, Medicare Part D plans have a maximum deductible set at $545. This is a slight increase from the 2023 deductible, which was $505, indicating a rise in the initial out-of-pocket costs for beneficiaries.

It’s important to include this deductible when calculating your yearly healthcare costs.


Initial Coverage Phase

The deductible phase is succeeded by the initial coverage phase. In this phase, a certain percentage of your drug costs is borne by you, while the balance is covered by your Part D plan. In 2025, you are expected to pay 25% of your total drug costs, while your Part D plan will pay the remaining 75%.

This cost-sharing continues until your total drug costs reach the threshold where the coverage gap begins. As previously discussed, the coverage gap is a phase where you pay a larger share of your drug costs.


Catastrophic Coverage Phase

The catastrophic phase, also known as the catastrophic coverage phase, commences when your out-of-pocket spending on your Medicare Part D plan touches $8,000.

Once you reach this phase, you will no longer have to pay copayments or coinsurance for the rest of the calendar year. In fact, you will no longer be responsible for any out-of-pocket spending on your covered Part D drugs.

Furthermore, starting in 2025, beneficiaries who reach catastrophic coverage will not be required to pay the 5% coinsurance, thus capping their out-of-pocket spending.

Compare Medicare Plans

Find a plan to fit your needs


Speak with a licensed insurance agent

TTY 711

Mon-Fri : 8am-9pm ET

Impact of the Inflation Reduction Act on Medicare Part D

In 2025, Medicare Part D will see significant changes due to the Inflation Reduction Act. This act introduces a drug spending cap, which will significantly decrease your out-of-pocket expenses for medications.

Additionally, it allows Medicare to negotiate directly with drug manufacturers to lower the prices of some costly drugs under Part B and Part D, starting in 2026.

The Inflation Reduction Act also impacts your premiums. A provision of the act caps the annual increase of Medicare Part D base beneficiary premiums to no more than 6% through 2029, helping stabilize premium costs.

Additionally, starting in 2025, the act expands eligibility for the Medicare Part D Low-Income Subsidy, ensuring full benefits for qualified recipients.


Strategies to Minimize Out-of-Pocket Costs in the Coverage Gap


2025 Medicare Coverage Gap Strategies to Minimize Out-of-Pocket Costs in the Coverage Gap


Despite modifications to Medicare Part D, multiple strategies remain to reduce your out-of-pocket costs during the coverage gap. One such strategy is to apply for the Extra Help program through Medicare and Social Security.

This program, also known as the Part D Low-Income Subsidy (LIS), offers more drug cost coverage for individuals with limited resources earning less than 150% of the federal poverty level.

Another strategy is to select a Medicare drug plan that provides additional coverage during the gap. While these plans might come with higher monthly premiums, they can lower your out-of-pocket costs.

Furthermore, switching from brand-name medications to generic or other lower-cost alternatives can offer significant savings during the coverage gap.

Lastly, you can utilize Pharmaceutical Assistance Programs offered by some drug manufacturers and State Pharmaceutical Assistance Programs, which can help cover medication costs.


Future Changes to Medicare Part D: 2025 and Beyond

Post-2025, additional modifications to Medicare Part D are anticipated. These modifications include:

  • The coverage gap phase, also known as the Donut Hole, will be eliminated in 2025.


  • A $2,000 cap on out-of-pocket drug costs will be introduced.


  • The 5% coinsurance requirement above the catastrophic threshold will be eliminated.


These changes aim to improve the affordability and accessibility of prescription drugs for Medicare beneficiaries.

Starting in 2025, Medicare will implement the following changes to its drug coverage:

  • Cost-sharing for brand-name drugs in the catastrophic coverage phase will decrease from 80% to 20%


  • Cost-sharing for generic drugs in the catastrophic coverage phase will decrease from 80% to 40%


  • Part D enrollees will have the option to distribute their out-of-pocket costs throughout the year starting in 2025


  • Medicare will begin to negotiate directly with drug manufacturers for certain high-cost drugs, with the first 10 drug prices effective in 2026


These changes aim to make prescription drugs more affordable for Medicare beneficiaries.


To wrap up, understanding Medicare Part D and the associated coverage gap is crucial for anyone enrolled in the program. In 2025, important changes are set to take effect, including the start of the coverage gap after $5,030 in drug costs and the exit from the gap after reaching $8,000 in out-of-pocket costs.

The Inflation Reduction Act is making significant changes to the program, including introducing a drug spending cap and allowing Medicare to negotiate drug prices directly with manufacturers.

Beneficiaries can minimize their out-of-pocket costs during the coverage gap by utilizing strategies like Extra Help, selecting plans with gap coverage, and switching to lower-cost alternatives.

Compare plans & rates for 2025
Enter Zip Code


Frequently Asked Questions


What will the Medicare donut hole be in 2025?

In 2025, the Medicare donut hole threshold will be $5,030, and during this phase, you will pay 25% of the cost of your covered drugs until your out-of-pocket costs reach $8,000.


What is the out-of-pocket limit for Medicare in 2025?

In 2025, the out-of-pocket limit for Medicare Advantage Plans is $8,850, but may be lower. Additionally, the 2025 out-of-pocket limits for Medigap plans K & L are $7,060 and $3,530, respectively.


Is the Medicare Part D donut hole going away in 2025?

Yes, the Medicare Part D donut hole will be eliminated in 2025.


What are the proposed changes to Medicare in 2025?

In 2025, Medicare Part B enrollees will see an increase in the standard monthly premium to $174.70. Additionally, changes to drug costs will include a cap of $3,250 and adjustments to payment percentages.


When does the coverage gap start in 2025?

The coverage gap in 2025 starts after you and your drug plan have spent a total of $5,030 on covered drugs.

call now

Compare Medicare Plans

Find a plan to fit your needs

Speak with a licensed insurance agent

TTY 711

Mon-Fri : 8am-9pm ET